StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.42−0.06 (-4.05%)

Close on Nov 17, 2026Market cap $53.14MP/E –Yield –

Tenax Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Tenax Therapeutics's market cap was $54.00M on Nov 11, 2026, against $55.71M a year earlier. Over the last 5 years it ranged from $740.26K to $41.93B, with a median of $73.90M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$54.00M-25.0%
2025Dec 31, 2025$72.01M+241.3%
2024Dec 31, 2024$21.10M-96.0%
2023Dec 29, 2023$524.21M-90.2%
2022Dec 30, 2022$5.34B-87.3%
2021Dec 31, 2021$41.93B+11.7%
2020Dec 31, 2020$37.56B+146.9%
2019Dec 31, 2019$15.21B+436.1%
2018Dec 31, 2018$2.84B-87.2%
2017Dec 29, 2017$22.14B-74.8%
2016Dec 30, 2016$87.73B-40.5%
2015Dec 31, 2015$147.57B-14.6%
2014Dec 31, 2014$172.77B+252.1%
2013Dec 31, 2013$49.06B+44.7%
2012Dec 31, 2012$33.90B-37.9%
2011Dec 30, 2011$54.59B–

More Tenax Therapeutics figures

See a number that looks wrong?